Professional Documents
Culture Documents
RLE Day1 of 3rdyear3
RLE Day1 of 3rdyear3
WELCOME TO THIS
NEW NORMAL SCHOOL
YEAR 2020-2021!!!
HOW ARE YOU???
Hello, hello, hello, how are you?
Hello, hello, hello, how are you?
I’m good.
I’m great!
I’m wonderful!
I’m good.
I’m great!
I’m wonderful!
Hello, hello, hello, how are you?
Hello, hello, hello, how are you?
I’m tired.
I’m hungry.
I’m not so good.
I’m tired.
I’m hungry.
I’m not so good.
Hello, hello, hello, how are you?
Hello, hello, hello, how are you?
Hello, hello, hello, how are you?
Hello, hello, hello, how are you?
https://youtu.be/lOrKCVNb-os
Knowing someone is there to listen to
you can somewhat lightens up your
day
Microsoft Office
Word Document
Guidelines in the Conduct of Classes
9
Guidelines in the Conduct of Classes
11
Grading System
12
Grading System (LEC)
13
RLE Course Calendar
Target Date Specific Topics Leads
Week No.
WEEK 1 D1-Course Overview/RLE Online Policies •Instructor
VMGO Awareness facilitates
What is the Normal Inflammatory Response? discussion
(Video viewing and PPT Presentation) •Student’s
understands
D2- Psoas, Obturator, Rovsing Test (Video Normal
Viewing, Return Demonstration) Inflammatory
response of the
D3- Pain Management (PPT and Return Body
Demonstration) • Student’s
Nursing Care Plan Making ( Pain) creates recorded
video of their
Return
Demonstration
WEEK 2 D4- Providing a Bed Pan (Video viewing and Return • Interative
Demonstration) Discussion
Benign Prostatic Hyperplasia •Student’s creates
recorded video of
D5- Heat and Cold Compress & Wound Care their Return
(Video Viewing ,Return Demonstration) Demonstration
D6- Case Presentation/Debate of A&B •Case
Recall of Duty study+Debate+exa
Evaluation mination to
evaluate students
learning
Target Date Specific Topics Leads
Week No.
16
VIEWING TIME
Normal
Inflammatory
Response
https://youtu.be/FXSuEIMrPQk
https://youtu.be/uc6IV85mf3s
https://youtu.be/qCpWXPSMBIY
https://youtu.be/Fbzb75HA9M8
Prothrombin-
(protein) A glycoprotein, produced in the liver,
that is converted into thrombin during
bleeding and subsequent clotting.